GW-468816

N/A

Report date: 2022/08/29 20:00:24
NME

Base Information

Drug NameGW-468816
Drug Alias NameGW-468816
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycine receptor antagonists
TargetsGlycine receptor
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsTobacco Use Disorder

Other Information

ATC CodeN/A
Related LinksDrugBank